Information provided by Ecsponent Biotech, (www.ecsbio.com) on behalf of:
This is for information and educational purposes only, and should not be construed
as healthcare advice. Please discuss with your healthcare professional. A full list of
references is available on the website and at our offices. Data on file.
DOC 9.0.1.105.9.SA V1 Effective date: 5 May 2017
Sample Releases
Blood stem cell transplants have been performed for more than
50 YEARS and have been used to treat or cure with more than 80
potentially life threatening blood related diseases like leukaemia,
lymphoma, bone marrow failures.
Blood stem cells used in transplants can be collected from:
• Bone marrow
• Circulating blood
• Umbilical cord blood
To date:
1 000 000+
blood stem cell transplants
have been done
with more than 1/3 using
cord blood
stem cells
Cord blood stem cells are also currently used
to treat:
1
2
3
1. Cerebral palsy
2. Autism
3. Diabetes (but only within critical trails)
Specialists involved, Joanne Kurtzbery & Colleen
Delaney are optimistic and started the Phase II
trials early this year.
Within the Cryo-Save Group internationally, there have been 18 stem cell release to date - to centres such as Duke
University North Carolina, USA, Kliniek Pediatrische Hematologie en Oncologie Frankfurt, Germany and Kinderspital Zurich,
Switzerland.
We also had one South African release, which was for diagnostic genetic
testing for acute lymphocytic leukaemia.
This confirms that Cryo-Save South Africa laboratory aligns with
international standards give you an indication of the standards of our cord
blood products.
14
have been for autologous
(own stem cells) & sibling
transplants
4/8
have been for
clinical trails for
cerebral palsy
